MENU
CLOV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CLOV stock forecast, quote, news & analysis

Clover Health Investments Corp is a healthcare technology company... Show more

CLOV
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for CLOV with price predictions
Sep 11, 2026

CLOV in +11.06% Uptrend, growing for three consecutive days on September 11, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CLOV advanced for three days, in 223 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 01, 2026. You may want to consider a long position or call options on CLOV as a result. In 62 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for CLOV just turned positive on September 01, 2026. Looking at past instances where CLOV's MACD turned positive, the stock continued to rise in 35 of 46 cases over the following month. The odds of a continued upward trend are 76%.

CLOV moved above its 50-day moving average on September 10, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

CLOV broke above its upper Bollinger Band on September 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CLOV entered a downward trend on September 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating fairly steady price growth. CLOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLOV's P/B Ratio (6.803) is slightly higher than the industry average of (3.775). P/E Ratio (0.000) is within average values for comparable stocks, (152.490). CLOV's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (0.929). CLOV's Dividend Yield (0.000) is considerably lower than the industry average of (0.020). P/S Ratio (1.027) is also within normal values, averaging (0.595).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 66.95B. The market cap for tickers in the group ranges from 1.01M to 340.27B. UNH holds the highest valuation in this group at 340.27B. The lowest valued company is IHGP at 1.01M.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 65%. CLOV experienced the highest price growth at 13%, while ALHC experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was 30%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was -8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 44
Price Growth Rating: 36
SMR Rating: 72
Profit Risk Rating: 85
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
CLOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ManagedHealthCare

Profile
Details
Industry
N/A
Address
3401 Mallory Lane
Phone
+1 201 432-2133
Employees
724
Web
https://www.cloverhealth.com
CLOV in +11.06% Uptrend, growing for three consecutive days on September 11, 2026